eCysticFibrosis Review

Pancreatic insufficiency. In children with CF, it’s been associated with delayed development and increased odds of developing severe lung disease. How can it be more accurately diagnosed? And what does the evidence say about the effects of treatment with CFTR modulators?That’s what we explore in this case-based podcast, with Dr. Vikesh Singh, Associate Professor of Medicine and Director of the Pancreatitis Center at Johns Hopkins Medical Institutions. Take ourpost-testto claim CME credits.Read this podcast's companion newsletter here.

Do cystic fibrosis lung impairment and the COVID-19 virus create the disastrous combination they would seem to make? What do the currently published data say about the clinical effects of the pandemic on people living with CF? How have the safety-mandated lockdowns and clinic closures affected CF care teams’ ability to effectively maintain their patients’ health? What information out there is proved, what’s speculation, and what is simply unknown?These questions are the focus of thiseCysticFibrosisReview Special COVID Editionissue.LisaSaimanMD, MPH,professor ofpediatrics atColumbia University Irving Medical Center,analyzes the current literature investigating these questions and then speaks directly with front-line clinicians about what they’re experiencing as they navigate adisrupted health care system.In addition to presenting her analysis of the data-driven evidence describing the effects of the COVID-19 virus on people with cystic fibrosis, Dr.Saimanalso spoke directly with front-line CF clinicians to learn about what they’ve been experiencing as they work to maintain effective patient care. Transcripts of these interviews can be accessed throughout the newsletter.Take ourpost-testto claim CME credits.

Do cystic fibrosis lung impairment and the COVID-19 virus create the disastrous combination they would seem to make? What do the currently published data say about the clinical effects of the pandemic on people living with CF? How have the safety-mandated lockdowns and clinic closures affected CF care teams’ ability to effectively maintain their patients’ health? What information out there is proved, what’s speculation, and what is simply unknown?These questions are the focus of this eCysticFibrosis Review Special COVID Edition issue.

Do cystic fibrosis lung impairment and the COVID-19 virus create the disastrous combination they would seem to make? What do the currently published data say about the clinical effects of the pandemic on people living with CF? How have the safety-mandated lockdowns and clinic closures affected CF care teams’ ability to effectively maintain their patients’ health? What information out there is proved, what’s speculation, and what is simply unknown?These questions are the focus of this eCysticFibrosis Review Special COVID Edition issue.

Do cystic fibrosis lung impairment and the COVID-19 virus create the disastrous combination they would seem to make? What do the currently published data say about the clinical effects of the pandemic on people living with CF? How have the safety-mandated lockdowns and clinic closures affected CF care teams’ ability to effectively maintain their patients’ health? What information out there is proved, what’s speculation, and what is simply unknown?These questions are the focus of this eCysticFibrosis Review Special COVID Edition issue.

Studies have shown that adolescent and young adult women with cystic fibrosis often turn to their CF care team for answersto their questionsabout their sexual and reproductive health. But how prepared areCFclinicians to initiate conversations? Do they have the most current data about pregnancy decisions for women taking CFTR modulators? When should modulator therapy be stopped? When is it safe to continue?In thiseCysticFibrosisReview podcast, Dr. TraciKazmerskifrom UPMC Children's Hospital of Pittsburgh and Dr. Natalie West fromJohns Hopkins Universitytake us into the clinic to address these important questions.To read a companion newsletterclick here.